LGL vs NVDA

LGL exhibits significant fundamental weakness, highlighted by a weak Piotroski F-Score of 3/9 and a current price ($7.28) that trades at a massive premium to both its Graham Number ($4.19) and Intrinsic Value ($0.77). While the company maintains an exceptionally clean balance sheet with virtually no debt and extreme liquidity, its operational efficiency is poor, evidenced by very low ROE (1.74%) and a dismal earnings track record. The stock appears to be priced for growth that is not supported by its current 5.4% revenue growth or its consistent failure to meet earnings estimates.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.